Immediate Impact
81 standout
Citing Papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Hypoxia-tropic delivery of nanozymes targeting transferrin receptor 1 for nasopharyngeal carcinoma radiotherapy sensitization
2025 Standout
Works of Quan Sing Ng being referenced
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
2016
Randomized phase III trial of concurrent chemoradiation with or without neoadjuvant gemcitabine, carboplatin, and paclitaxel in locally advanced nasopharyngeal cancer.
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Quan Sing Ng | 491 | 379 | 569 | 63 | 1.2k | |
| Antonio Gómez‐Caamaño | 466 | 308 | 467 | 71 | 1.0k | |
| M.I. Saunders | 447 | 272 | 375 | 56 | 1.2k | |
| Cihan Gani | 480 | 491 | 537 | 86 | 1.2k | |
| Florian Würschmidt | 493 | 322 | 303 | 49 | 1.0k | |
| Florence K. Keane | 500 | 517 | 183 | 57 | 1.2k | |
| Bhanu Prasad Venkatesulu | 346 | 508 | 322 | 51 | 1.1k | |
| Henry Mandeville | 629 | 244 | 582 | 72 | 1.2k | |
| J.H. Heinzerling | 712 | 318 | 332 | 56 | 1.1k | |
| Houda Bahig | 716 | 357 | 546 | 114 | 1.4k | |
| Ajay Sandhu | 632 | 187 | 407 | 69 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...